Financial Performance - The company's operating revenue for Q1 2025 was ¥104,943,144.28, a decrease of 3.62% compared to ¥108,881,781.06 in the same period last year[5] - Net profit attributable to shareholders was ¥22,059,641.87, representing an increase of 2.58% from ¥21,504,922.08 year-on-year[5] - Basic earnings per share for Q1 2025 were ¥0.0780, up 2.50% from ¥0.0761 in the same period last year[5] - Net profit for the current period increased by 9.2% to ¥21,502,375.38 compared to ¥19,689,324.27 in the previous period[18] - Earnings per share (EPS) for the current period was ¥0.0780, up from ¥0.0761 in the previous period[18] Cash Flow and Liquidity - The net cash flow from operating activities increased by 458.28%, reaching ¥20,993,336.25, compared to a negative cash flow of ¥5,859,400.09 in the previous year[9] - The net cash flow from operating activities was $20,993,336.25, a significant improvement from a negative cash flow of $5,859,400.09 in the previous period, indicating a recovery in operational efficiency[20] - The net cash flow from investment activities was $8,141,348.87, recovering from a negative cash flow of $4,680,728.28 previously, showcasing effective asset management[20] - The net increase in cash and cash equivalents for the period was $29,134,685.12, contrasting with a decrease of $10,540,128.37 in the previous period, indicating improved liquidity[21] - The ending balance of cash and cash equivalents reached $581,678,770.07, up from $477,347,078.17 at the end of the previous period, reflecting a stronger cash position[21] Assets and Equity - Total assets at the end of the reporting period were ¥1,501,614,360.67, reflecting a growth of 0.85% from ¥1,488,952,832.62 at the end of the previous year[5] - Shareholders' equity attributable to the parent company increased by 1.57% to ¥1,427,511,641.43 from ¥1,405,451,999.56[5] - Total assets increased to ¥1,501,614,360.67 from ¥1,488,952,832.62, reflecting a growth of 0.9%[15] - Total equity attributable to shareholders increased to ¥1,427,511,641.43 from ¥1,405,451,999.56, marking a growth of 1.6%[15] Costs and Expenses - Total operating costs decreased by 6.0% to ¥82,148,198.66 from ¥87,235,482.44, with operating costs specifically down by 4.2% to ¥67,586,957.14[17] - Research and development expenses decreased significantly by 37.9% to ¥3,166,228.24 from ¥5,096,005.31[17] - Cash paid for purchasing goods and services decreased to $51,618,125.65 from $77,319,695.23, suggesting improved cost management[20] Other Financial Aspects - The company reported a loss of ¥744,008.99 from the disposal of non-current assets, primarily due to losses from biological assets[7] - Government subsidies recognized in the current period amounted to ¥741,003.18, contributing positively to the financial results[7] - The company has strengthened its management of procurement payments, which significantly improved cash flow from operations[9] - The first quarter report was not audited, which may affect the perception of financial reliability[22] - The cash flow statement for the current period is yet to be detailed, indicating potential areas for further analysis[19] - The total number of ordinary shareholders at the end of the reporting period was 23,892[11] - The company reported a credit impairment loss of ¥581.81, contrasting with a gain of ¥24,320.34 in the previous period[18] - Cash received from sales of goods and services was $120,093,669.14, slightly up from $119,958,994.41, indicating stable revenue generation[20] - Cash received from tax refunds increased to $1,607.85 from $148.16, indicating better tax recovery processes[20] - The company did not report any cash inflows from financing activities, indicating a focus on internal funding sources[21]
阳光乳业(001318) - 2025 Q1 - 季度财报